Makrocare Clinical Research Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
as on 31-07-2024
- Paid Up Capital ₹ 6.65 Cr
as on 31-07-2024
- Company Age 16 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -3.34%
(FY 2023)
- Profit 30.65%
(FY 2023)
- Ebitda 115.92%
(FY 2023)
- Net Worth -7.72%
(FY 2023)
- Total Assets 1.00%
(FY 2023)
About Makrocare Clinical Research
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 6.65 Cr, as per Ministry of Corporate Affairs (MCA) records.
Subba Malneedi, Kanaka Durga, Vishnumurty Nidadavolu, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232TG2008PLC057098
- Company No.
057098
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 Jan 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Makrocare Clinical Research Limited offer?
Makrocare Clinical Research Limited offers a wide range of products and services, including Software Development & IT Consultant, IT Security Service.
Who are the key members and board of directors at Makrocare Clinical Research?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subba Malneedi  | Managing Director | 10-Jan-2008 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kanaka Durga | Director | 10-Jan-2008 | Current |
| Vishnumurty Nidadavolu | Director | 10-Jan-2008 | Current |
| Sreevalli Nidadavolu | Director | 19-Mar-2009 | Current |
Financial Performance of Makrocare Clinical Research.
Makrocare Clinical Research Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.34% decrease. The company also saw a substantial improvement in profitability, with a 30.65% increase in profit. The company's net worth dipped by a decrease of 7.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Makrocare Clinical Research?
In 2023, Makrocare Clinical Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vns Makro Technologies Private LimitedActive 27 years 5 monthsSubba Malneedi, Kanaka Durga and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Makrocare Clinical Research?
Makrocare Clinical Research has a workforce of 56 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Makrocare Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Makrocare Clinical Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
